From MedCityNews: A 2017 study of 177 publicly-listed biotech companies found women hold just 1 in 10 board seats. And 2012 research from Rock Health showed women make up 4 percent of healthcare company CEOs.
Originally posted on Xconomy.com: It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference.
There has been plenty of talk since about closing biotech’s notable gender gap. At this year’s J.P Morgan conference, for example, a group of 100 life science executives and others pledged to follow a list of gender diversity “best practices.”